About Benedic Pharmaceuticals Private Limited
Data last updated:
Benedic Pharmaceuticals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U51909UR2016PTC001952. Its GSTIN is 05AAGCB6799J1Z4 (Uttarakhand).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors including Piyush Arora and Shantanu Virmani.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 88 Sector – Iidc Sidcul, Haridwar, Uttarakhand, India – 249403.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.81 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹14.16 Lakh (net margin 5%) and EBITDA of ₹48.31 Lakh (EBITDA margin 17.2%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 20% over five years.
The company is associated with 1 brand: Benedic Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.54 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website benedicpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 88 Sector – Iidc Sidcul, Haridwar, Uttarakhand, India – 249403
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Benedic Pharmaceuticals Private Limited
The main business activity of Benedic Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Benedic Pharmaceuticals Private Limited FY 2025 filings available
Benedic Pharmaceuticals Private Limited reported revenue of ₹2.81 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Benedic Pharmaceuticals Private Limited
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Benedic Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹48.31 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14.16 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Benedic Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Benedic Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Benedic Pharmaceuticals Private Limited
Benedic Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sabhika Pharmaceuticals Private Limited | ₹2.83 Cr (FY 2025) | •••• | •••• | 218.0% | •••• | Bangalore, Karnataka, India |
| Bhavyas Pharmaceuticals Private Limited | ₹2.83 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Medak, Telangana, India |
| Synaptics Pharmaceuticals Private Limited | ₹2.82 Cr (FY 2024) | •••• | •••• | -36.0% | •••• | Hyderabad, Telangana, India |
| Karad and Patil Pharmaceuticals Private Limited | ₹2.82 Cr (FY 2022) | •••• | •••• | 3274.0% | •••• | Latur, Maharashtra, India |
| Amazone Pharmaceuticals Private Limited | ₹2.82 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Delhi, India |
| Benedic Pharmaceuticals Private Limited this company | ₹2.81 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Haridwar, Uttarakhand, India |
| Base Pharmaceuticals Private Limited | ₹2.8 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Punjab, India |
| Jammi Pharmaceuticals Private Limited | ₹2.8 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| P and B Pharmaceuticals Private Limited | ₹2.8 Cr (FY 2025) | •••• | •••• | -38.0% | •••• | Mumbai, Maharashtra, India |
| Zavix Pharmaceuticals Private Limited | ₹2.79 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | South Bopal, Ahmedabad, Gujarat, India |
| Parex Pharmaceuticals Private Limited | ₹2.78 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Punjab, India |
Peers are the five companies nearest above and the five nearest below Benedic Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Benedic Pharmaceuticals Private Limited
Benedic Pharmaceuticals Private Limited is audited by ANIL SONALI & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANIL SONALI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Benedic Pharmaceuticals Private Limited
Benedic Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Piyush Arora | Director | 14 Mar 2016 | 10 Years 6 Months | Current |
| Shantanu Virmani Also directs: BLS the Elite Club LLP, QCD Agro LLP, Zaneka Pharmaceuticals Private Limited and 1 more | Director | 14 Mar 2016 | 10 Years 6 Months | Current |
| Indu Batra Also directs: Zaneka Pharmaceuticals Private Limited | Director | 14 Mar 2016 | 10 Years 6 Months | Current |
Ownership and Shareholding of Benedic Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Benedic Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2024 | Hdfc Bank Limited | ₹14.39 Lakh | Open |
| 17 Jul 2022 | Hdfc Bank Limited | ₹1.2 Cr | Open |
| 27 Apr 2022 | Hdfc Bank Limited | ₹20.08 Lakh | Open |
Total charge records: 3 View all charges
Associated Brands with Benedic Pharmaceuticals Private Limited
Benedic Pharmaceuticals operates one associated brand: Benedic Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a distributor of a wide range of pharmaceutical drugs for healthcare providers. | benedicpharma.com |
Employees and EPFO Compliance at Benedic Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Benedic Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Benedic Pharmaceuticals Private Limited
Benedic Pharmaceuticals Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Indu Batra was appointed as Director on 14 Mar 2016.
Credit Ratings, Litigation & Regulatory Alerts for Benedic Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Benedic Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Benedic Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Benedic Pharmaceuticals Private Limited
Benedic Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAGCB6799J1Z4 | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Benedic Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Benedic Pharmaceuticals Private Limited
Benedic Pharmaceuticals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 March 2016 (10+ years old) and is registered under CIN U51909UR2016PTC001952.
Benedic Pharmaceuticals reported revenue of ₹2.81 Cr for FY 2025 (down 1% YoY).
Benedic Pharmaceuticals has 3 current directors:
- Piyush Arora - Director
- Shantanu Virmani - Director
- Indu Batra - Director
Benedic Pharmaceuticals reported a net profit of ₹14.16 Lakh (net margin 5%) and EBITDA of ₹48.31 Lakh (EBITDA margin 17.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Benedic Pharmaceuticals is 4% over three years and 20% over five years. In the latest year (FY 2025) revenue fell 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Benedic Pharmaceuticals is 05AAGCB6799J1Z4, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Benedic Pharmaceuticals is U51909UR2016PTC001952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Benedic Pharmaceuticals was incorporated on 14 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Benedic Pharmaceuticals by revenue are Sabhika Pharmaceuticals Private Limited, Bhavyas Pharmaceuticals Private Limited, Synaptics Pharmaceuticals Private Limited, Karad and Patil Pharmaceuticals Private Limited, Amazone Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Indu Batra was appointed as Director on 14 Mar 2016. Piyush Arora was appointed as Director on 14 Mar 2016. Shantanu Virmani was appointed as Director on 14 Mar 2016.
Benedic Pharmaceuticals can be reached through the website benedicpharma.com. Its registered office is in Haridwar, Uttarakhand, India.